BIOSYNTH CARBOSYNTH & Design — 1989733
Application number
1989733
Registration number
TMA1126962
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2019-10-10
Registered
2022-04-27
Registration Expiry Date
2032-04-27
Registered Owner
Biosynth AG (a Switzerland corporation)
P.O. Box 125
Staad, 9422
SWITZERLAND
Agent
DENTONS CANADA LLP
99 BANK STREET
SUITE 1420
OTTAWA
ONTARIO K1P1H4
Documents
Index headings
- BIOSYNTH CARBOSYNTH
- BIO SYNTH
- CARBO SYNTH
Vienna information (Code & Description)
- 26.4.2
- Rectangles
- A 26.4.5
- One quadrilateral
- 26.4.12
- Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).
- A 26.4.18
- Quadrilaterals containing one or more letters
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
- 26.11.1
- One line or one band
- A 26.11.8
- Horizontal lines or bands
- A 26.11.10
- Straight lines or bands
- 29.1.4
- Blue
- 29.1.6
- White, grey, silver
Colour claim
Colour is claimed as a feature of the trademark. The colours blue, grey and white are claimed as a feature of the mark. The mark consists of the stylized word BIOSYNTH in blue on top of a blue rectangle with the stylized word CARBOSYNTH in white inside the rectangle with a grey line underneath the rectangle.
Goods (Nice class & Statement)
- 1
- (1) Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, enzyme inactivators, and cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics
- 5
- (2) Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme preparations for medical and veterinary laboratory purposes
Claims
- Priority Filing Date: July 23, 2019, Country or Office: UNITED STATES OF AMERICA, Application No. 88/530,605 in association with the same kind of goods (1)
- Priority Filing Date: July 23, 2019, Country or Office: UNITED STATES OF AMERICA, Application No. 88/530,605 in association with the same kind of goods (2)
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2019-10-10 | ||
| Created | 2019-10-10 | ||
| Formalized | 2019-10-25 | ||
| Search Recorded | 2021-07-12 | ||
| Examiner's First Report | 2021-07-12 | 2022-01-12 | |
| Approved | 2021-12-02 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2021-12-02 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2022-02-09 | Vol.69 Issue 3511 | |
| Registration Pending | 2022-04-27 | ||
| Registered | 2022-04-27 | 2032-04-27 |